These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

650 related articles for article (PubMed ID: 25620151)

  • 1. Incidence and relevance of nonreentrant monomorphic ventricular tachycardia in patients with frequent implantable cardioverter defibrillator interventions.
    Fiek M; Remp T; Fleckenstein M; Pohl T; Deiss M; Reithmann C
    J Interv Card Electrophysiol; 2015 Mar; 42(2):151-60. PubMed ID: 25620151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiofrequency catheter ablation of sustained ventricular tachycardia in idiopathic dilated cardiomyopathy.
    Kottkamp H; Hindricks G; Chen X; Brunn J; Willems S; Haverkamp W; Block M; Breithardt G; Borggrefe M
    Circulation; 1995 Sep; 92(5):1159-68. PubMed ID: 7648661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rescue ablation of electrical storm in patients with ischemic cardiomyopathy: a potential-guided ablation approach by modifying substrate of intractable, unmappable ventricular tachycardias.
    Schreieck J; Zrenner B; Deisenhofer I; Schmitt C
    Heart Rhythm; 2005 Jan; 2(1):10-4. PubMed ID: 15851257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonischemic cardiomyopathy substrate and ventricular tachycardia in the setting of coronary artery disease.
    Aldhoon B; Tzou WS; Riley MP; Lin D; Callans DJ; Hutchinson MD; Dixit S; Garcia FC; Zado ES; Marchlinski FE
    Heart Rhythm; 2013 Nov; 10(11):1622-7. PubMed ID: 23973949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Substrate-modification using electroanatomical mapping in sinus rhythm to treat ventricular tachycardia in patients with ischemic cardiomyopathy.
    Deneke T; Grewe PH; Lawo T; Calcum B; Mügge A; Lemke B
    Z Kardiol; 2005 Jul; 94(7):453-60. PubMed ID: 15997346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Irrigated radiofrequency catheter ablation guided by electroanatomic mapping for recurrent ventricular tachycardia after myocardial infarction: the multicenter thermocool ventricular tachycardia ablation trial.
    Stevenson WG; Wilber DJ; Natale A; Jackman WM; Marchlinski FE; Talbert T; Gonzalez MD; Worley SJ; Daoud EG; Hwang C; Schuger C; Bump TE; Jazayeri M; Tomassoni GF; Kopelman HA; Soejima K; Nakagawa H;
    Circulation; 2008 Dec; 118(25):2773-82. PubMed ID: 19064682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ablation of ventricular arrhythmias in arrhythmogenic right ventricular dysplasia/cardiomyopathy: arrhythmia-free survival after endo-epicardial substrate based mapping and ablation.
    Bai R; Di Biase L; Shivkumar K; Mohanty P; Tung R; Santangeli P; Saenz LC; Vacca M; Verma A; Khaykin Y; Mohanty S; Burkhardt JD; Hongo R; Beheiry S; Dello Russo A; Casella M; Pelargonio G; Santarelli P; Sanchez J; Tondo C; Natale A
    Circ Arrhythm Electrophysiol; 2011 Aug; 4(4):478-85. PubMed ID: 21665983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significance of clinical ventricular tachycardias induced by antitachycardia pacing in patients with prior myocardial infarction.
    Sharaf-Dabbagh G; Siontis KC; Latchamsetty R; Jongnarangsin K; Yokokawa M; Lathkar-Pradhan S; Morady F; Bogun F
    Heart Rhythm; 2019 Apr; 16(4):544-550. PubMed ID: 30366159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ventricular Tachycardia with ICD Shocks: When to Medicate and When to Ablate.
    AbdelWahab A; Sapp J
    Curr Cardiol Rep; 2017 Sep; 19(11):105. PubMed ID: 28900864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Catheter ablation for the treatment of electrical storm in patients with implantable cardioverter-defibrillators: short- and long-term outcomes in a prospective single-center study.
    Carbucicchio C; Santamaria M; Trevisi N; Maccabelli G; Giraldi F; Fassini G; Riva S; Moltrasio M; Cireddu M; Veglia F; Della Bella P
    Circulation; 2008 Jan; 117(4):462-9. PubMed ID: 18172038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of substrate-based ablation for ventricular tachycardia in patients with frequent appropriate implantable cardioverter-defibrillator therapy and dilated cardiomyopathy: Long-term experience with high-density mapping.
    Oliveira M; Cunha P; Valente B; Portugal G; Lousinha A; Pereira M; Braz M; Delgado A; Ferreira RC
    Rev Port Cardiol (Engl Ed); 2021 Nov; 40(11):865-873. PubMed ID: 34857160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The value of defibrillator electrograms for recognition of clinical ventricular tachycardias and for pace mapping of post-infarction ventricular tachycardia.
    Yoshida K; Liu TY; Scott C; Hero A; Yokokawa M; Gupta S; Good E; Morady F; Bogun F
    J Am Coll Cardiol; 2010 Sep; 56(12):969-79. PubMed ID: 20828650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reasons for recurrent ventricular tachycardia after catheter ablation of post-infarction ventricular tachycardia.
    Yokokawa M; Desjardins B; Crawford T; Good E; Morady F; Bogun F
    J Am Coll Cardiol; 2013 Jan; 61(1):66-73. PubMed ID: 23122796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Indications for catheter ablation of ventricular tachycardia].
    Deneke T; Israel CW; Krug J; Nentwich K; Müller P; Mügge A; Schade A
    Dtsch Med Wochenschr; 2013 Sep; 138(39):1952-6. PubMed ID: 24046136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-density substrate-guided ventricular tachycardia ablation: role of activation mapping in an attempt to improve procedural effectiveness.
    Carbucicchio C; Ahmad Raja N; Di Biase L; Volpe V; Dello Russo A; Trivedi C; Bartoletti S; Zucchetti M; Casella M; Russo E; Santangeli P; Moltrasio M; Tundo F; Fassini G; Natale A; Tondo C
    Heart Rhythm; 2013 Dec; 10(12):1850-8. PubMed ID: 24055940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Focal Ventricular Tachycardias in Structural Heart Disease: Prevalence, Characteristics, and Clinical Outcomes After Catheter Ablation.
    Anderson RD; Lee G; Trivic I; Campbell T; Pham T; Nalliah C; Kizana E; Thomas SP; Trivedi SJ; Watts T; Kalman J; Kumar S
    JACC Clin Electrophysiol; 2020 Jan; 6(1):56-69. PubMed ID: 31971907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Catheter ablation of ventricular arrhythmia in nonischemic cardiomyopathy: anteroseptal versus inferolateral scar sub-types.
    Oloriz T; Silberbauer J; Maccabelli G; Mizuno H; Baratto F; Kirubakaran S; Vergara P; Bisceglia C; Santagostino G; Marzi A; Sora N; Roque C; Guarracini F; Tsiachris D; Radinovic A; Cireddu M; Sala S; Gulletta S; Paglino G; Mazzone P; Trevisi N; Della Bella P
    Circ Arrhythm Electrophysiol; 2014 Jun; 7(3):414-23. PubMed ID: 24785410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Frequent ventricular tachycardias: antiarrhythmic drug treatment or catheter ablation?].
    Tanner H; Hindricks G; Kottkamp H
    Herz; 2005 Nov; 30(7):613-8. PubMed ID: 16333587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prophylactic catheter ablation for induced monomorphic ventricular tachycardia in patients with implantable cardioverter defibrillators as primary prevention.
    Hayashi T; Fukamizu S; Hojo R; Komiyama K; Tanabe Y; Tejima T; Soejima K; Nishizaki M; Hiraoka M; Ako J; Momomura S; Sakurada H
    Europace; 2013 Oct; 15(10):1507-15. PubMed ID: 23603305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First-Line Catheter Ablation of Monomorphic Ventricular Tachycardia in Cardiomyopathy Concurrent With Defibrillator Implantation: The PAUSE-SCD Randomized Trial.
    Tung R; Xue Y; Chen M; Jiang C; Shatz DY; Besser SA; Hu H; Chung FP; Nakahara S; Kim YH; Satomi K; Shen L; Liang E; Liao H; Gu K; Jiang R; Jiang J; Hori Y; Choi JI; Ueda A; Komatsu Y; Kazawa S; Soejima K; Chen SA; Nogami A; Yao Y;
    Circulation; 2022 Jun; 145(25):1839-1849. PubMed ID: 35507499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.